As part of the strategy to strengthen links at a global level, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) participated in the work of India Pharma 2018, where it presented the regulatory advances reported by Mexico to expedite the population’s access to medicines and supplies for quality, safety and efficacy.

For more information go to